| Symbol | Price | Change | % Change |
|---|
Analyst | Recommendation | Action | Price Target | Projected | Date |
|---|---|---|---|---|---|
David Vernon Bernstein | Buy | Maintained | $424.00 | +31.5% | 06/21/2026 |
Christian Wetherbee Wells Fargo | Buy | Reiterated | $425.00 | +31.8% | 06/17/2026 |
Brandon Oglenski Barclays | Buy | Maintained | $425.00 | +31.8% | 06/12/2026 |
Ravi Shanker Morgan Stanley | Sell | Maintained | $160.00 | -50.4% | 06/03/2026 |
Ken Hoexter Bank of America Securities | Buy | Reiterated | $376.00 | +16.6% | 06/02/2026 |
Jordan Alliger Goldman Sachs | Buy | Maintained | $375.00 | +16.3% | 06/01/2026 |
Brian Ossenbeck J.P. Morgan | Buy | Upgraded | $460.00 | +42.7% | 05/27/2026 |
Thomas Wadewitz UBS | Buy | Reiterated | $445.00 | +38% | 05/22/2026 |
Ariel Rosa Citi | Buy | Maintained | $443.00 | +37.4% | 05/21/2026 |
J. Bruce Chan Stifel Nicolaus | Buy | Maintained | $442.00 | +37.1% | 04/13/2026 |
Stephanie Moore Jefferies | Buy | Reiterated | $450.00 | +39.6% | 04/10/2026 |
Jonathan Chappell Evercore ISI | Hold | Maintained | $390.00 | +21% | 04/09/2026 |
Fadi Chamoun BMO Capital | Hold | Maintained | $410.00 | +27.2% | 04/09/2026 |
Lucas Servera Truist Financial | Buy | Maintained | - | - | 04/09/2026 |
Scott Group Wolfe Research | Buy | Maintained | $423.00 | +31.2% | 04/07/2026 |
Kristina Ruggeri Argus Research | Buy | Maintained | $400.00 | +24.1% | 04/06/2026 |
Richa Harnain Deutsche Bank | Buy | Maintained | $479.00 | +48.6% | 03/23/2026 |
Parash Jain HSBC | Hold | Upgraded | $360.00 | +11.6% | 03/20/2026 |
Bascome Majors Susquehanna | Buy | Maintained | $455.00 | +41.1% | 03/20/2026 |
Reed Seay Stephens | Buy | Maintained | $435.00 | +34.9% | 03/20/2026 |
Jason Seidl TD Cowen | Buy | Reiterated | $426.00 | +32.1% | 03/20/2026 |
All values in USD | May 2025 | Aug 2025 | Nov 2025 | Feb 2026 |
|---|---|---|---|---|
Revenue | 22.22B | 22.24B | 23.47B | 24.00B |
Cost of goods sold | 15.29B | 16.40B | 17.21B | 17.71B |
Cost of revenue | 15.29B | 16.40B | 17.21B | 17.71B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 425.00M | - | - | - |
Operating expense | 4.39B | 4.49B | 4.59B | 4.63B |
Total operating expenses | 19.68B | 20.89B | 21.80B | 22.33B |
Operating income | 2.54B | 1.35B | 1.67B | 1.67B |
Other non operating income | 8.00M | 9.00M | -13.00M | -5.00M |
EBT including unusual items | 2.22B | 1.13B | 1.29B | 1.26B |
EBT excluding unusual items | 2.42B | 1.24B | 1.52B | 1.52B |
Income tax expense | 575.00M | 310.00M | 333.00M | 207.00M |
Effective tax rate | 25.87% | 27.34% | 25.83% | 16.39% |
Other operating expenses | 2.91B | 3.40B | 3.52B | 3.52B |
Net income | 1.65B | 824.00M | 956.00M | 1.06B |
Net profit margin | 7.42% | 3.70% | 4.07% | 4.40% |
Earnings per share | 6.07 | 3.83 | 4.82 | 5.25 |
Interest and investment income | 363.00M | - | - | - |
Interest expense | -487.00M | -119.00M | -135.00M | -138.00M |
Net interest expenses | -124.00M | -119.00M | -135.00M | -138.00M |
Depreciation and amortization charges | 1.06B | 1.09B | 1.07B | 1.11B |
EBITDA | 3.60B | 2.45B | 2.74B | 2.78B |
Gain or loss from assets sale | - | - | - | - |
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|